216 related articles for article (PubMed ID: 18781607)
21. ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.
Andress EJ; Nicolaou M; McGeoghan F; Linton KJ
Cell Mol Life Sci; 2017 Jul; 74(13):2513-2524. PubMed ID: 28220208
[TBL] [Abstract][Full Text] [Related]
22. ABCB4 sequence variations in young adults with cholesterol gallstone disease.
Nakken KE; Labori KJ; Rødningen OK; Nakken S; Berge KE; Eiklid K; Raeder MG
Liver Int; 2009 May; 29(5):743-7. PubMed ID: 19018976
[TBL] [Abstract][Full Text] [Related]
23. Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation.
Goubran M; Aderibigbe A; Jacquemin E; Guettier C; Girgis S; Bain V; Mason AL
BMC Med Genet; 2020 Nov; 21(1):238. PubMed ID: 33256620
[TBL] [Abstract][Full Text] [Related]
24. Hypomorphic mutations in meckelin (MKS3/TMEM67) cause nephronophthisis with liver fibrosis (NPHP11).
Otto EA; Tory K; Attanasio M; Zhou W; Chaki M; Paruchuri Y; Wise EL; Wolf MT; Utsch B; Becker C; Nürnberg G; Nürnberg P; Nayir A; Saunier S; Antignac C; Hildebrandt F
J Med Genet; 2009 Oct; 46(10):663-70. PubMed ID: 19508969
[TBL] [Abstract][Full Text] [Related]
25. Cholestatic liver disease.
Jüngst C; Lammert F
Dig Dis; 2013; 31(1):152-4. PubMed ID: 23797137
[TBL] [Abstract][Full Text] [Related]
26. Destructive intrahepatic bile duct diseases.
Desmet VJ
Recenti Prog Med; 1990 Jun; 81(6):392-8. PubMed ID: 2251446
[TBL] [Abstract][Full Text] [Related]
27. Clinical and genetic study of ABCB4 gene-related cholestatic liver disease in China: children and adults.
Cao L; Ling X; Yan J; Feng D; Dong Y; Xu Z; Wang F; Zhu S; Gao Y; Cao Z; Zhang M
Orphanet J Rare Dis; 2024 Apr; 19(1):157. PubMed ID: 38610052
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a Novel Missense Mutation in
Saleem K; Cui Q; Zaib T; Zhu S; Qin Q; Wang Y; Dam J; Ji W; Liu P; Jia X; Wu J; Bai J; Fu S; Sun W
Dis Markers; 2020; 2020():6292818. PubMed ID: 32626542
[TBL] [Abstract][Full Text] [Related]
29. A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients.
Kruk B; Milkiewicz M; Raszeja-Wyszomirska J; Milkiewicz P; Krawczyk M
Orphanet J Rare Dis; 2022 Nov; 17(1):419. PubMed ID: 36397154
[TBL] [Abstract][Full Text] [Related]
30. Common ABCB4 and ABCB11 Genotypes Are Associated with Idiopathic Chronic Cholestasis in Adults.
Jüngst C; Justinger C; Fischer J; Berg T; Lammert F
Dig Dis; 2022; 40(4):489-496. PubMed ID: 34348275
[TBL] [Abstract][Full Text] [Related]
31. Hepatoma in familial cholestatic cirrhosis of childhood: its occurrence in twin brothers.
Dahms BB
Arch Pathol Lab Med; 1979 Jan; 103(1):30-3. PubMed ID: 215101
[TBL] [Abstract][Full Text] [Related]
32. ABCB4: Insights from pathobiology into therapy.
Falguières T; Aït-Slimane T; Housset C; Maurice M
Clin Res Hepatol Gastroenterol; 2014 Oct; 38(5):557-63. PubMed ID: 24953525
[TBL] [Abstract][Full Text] [Related]
33. Expanding the mutational spectrum of the ABCB4 gene in inherited adult cholestatic liver disorders with four novel pathogenic variants.
Huynh MT; Delaunay JL; Muller L; Corpechot C; Tran CT; Barbu V
Rev Esp Enferm Dig; 2019 Jan; 111(1):76-79. PubMed ID: 30449124
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and genetic profiles of young and adult patients with cholestatic liver disease.
Huynh MT; Nguyen TT; Grison S; Lascols O; Fernandez E; Barbu V
Rev Esp Enferm Dig; 2019 Oct; 111(10):775-788. PubMed ID: 31538484
[TBL] [Abstract][Full Text] [Related]
35. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.
Jacquemin E; De Vree JM; Cresteil D; Sokal EM; Sturm E; Dumont M; Scheffer GL; Paul M; Burdelski M; Bosma PJ; Bernard O; Hadchouel M; Elferink RP
Gastroenterology; 2001 May; 120(6):1448-58. PubMed ID: 11313315
[TBL] [Abstract][Full Text] [Related]
36. Clinical features and genotype-phenotype correlations in children with progressive familial intrahepatic cholestasis type 3 related to ABCB4 mutations.
Colombo C; Vajro P; Degiorgio D; Coviello DA; Costantino L; Tornillo L; Motta V; Consonni D; Maggiore G;
J Pediatr Gastroenterol Nutr; 2011 Jan; 52(1):73-83. PubMed ID: 21119540
[TBL] [Abstract][Full Text] [Related]
37. Liver pathology in severe multidrug resistant 3 protein deficiency: a series of 10 pediatric cases.
Vij M; Safwan M; Shanmugam NP; Rela M
Ann Diagn Pathol; 2015 Oct; 19(5):277-82. PubMed ID: 26117383
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4.
Andress EJ; Nicolaou M; Romero MR; Naik S; Dixon PH; Williamson C; Linton KJ
Hepatology; 2014 May; 59(5):1921-31. PubMed ID: 24806754
[TBL] [Abstract][Full Text] [Related]
39. Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders.
Vleggaar FP; Van Ooteghem NA; Van Buuren HR; Van Berge Henegouwen GP
Scand J Gastroenterol Suppl; 2000; (232):86-92. PubMed ID: 11232499
[TBL] [Abstract][Full Text] [Related]
40. X-linked idiopathic infantile nystagmus associated with a missense mutation in FRMD7.
Shiels A; Bennett TM; Prince JB; Tychsen L
Mol Vis; 2007 Nov; 13():2233-41. PubMed ID: 18087240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
